UPCOMING SESSIONS in ET
Wed, Jun 17, 2026
10:00 – 12:00 AM Bangkok
ATTR Newly Diagnosed Patients Onboarding Session Dr. Stacey Goodman Click Here To Register
UPCOMING SESSIONS in ET
Wed, Jun 17, 2026 · 10:00 – 12:00 AM Bangkok
ATTR Newly Diagnosed Patients Onboarding Session
Dr. Stacey Goodman
Click Here To Register
View all sessions
Documenting my dad's journey with AL Amyloidosis. "When oceans rise, my soul will rest in Your embrace. For I am Yours and You are mine!"
Hematologist and Oncologist, Director, Amyloidosis Center @amyloidosis_bu. Hematologist and Oncologist @The_BMC
Supporting patients and families while promoting research, education and awareness.
Cardiologist at Mayo Clinic. Former junior #Musketeer. #amyloidosis and #echo. Tweets limited to medicine and #Xavier basketball. My own and not my employer's.
Eidos Therapeutics, a subsidiary of BridgeBio Pharma, is developing AG10 as a targeted therapeutic for transthyretin amyloidosis. The company's singular mission is…
Dr. Suzanne Lentzsch, MD, PhD. Director of the Multiple Myeloma and Amyloidosis Service at Columbia University Medical Center.
Nephros is a commercial stage medical device company that develops and sells high-performance liquid purification filters. Nephros filters capture contaminants as…
Stanford IM residency program director, Cardiologist, Specialist in Amyloidosis, Cardio-Oncology, and Advanced heart failure.
BSIM's mission is to deliver quality drug candidates with high capital efficiency against transthyretin-mediated amyloidosis, including clinical manifestations and…
Twitter Handle: Director, Cardiac Amyloidosis Program, Brigham and Women's Hospital and Harvard Medical School.